1 Market Overview of Virtual Clinical Trials

• 1.1 Virtual Clinical Trials Market Overview
  • 1.1.1 Virtual Clinical Trials Product Scope
  • 1.1.2 Market Status and Outlook
• 1.2 Global Virtual Clinical Trials Market Size Overview by Region 2015 VS 2020 VS 2026
• 1.3 Global Virtual Clinical Trials Market Size by Region (2015-2026)
• 1.4 Global Virtual Clinical Trials Historic Market Size by Region (2015-2020)
• 1.5 Global Virtual Clinical Trials Market Size Forecast by Region (2021-2026)
• 1.6 Key Regions, Virtual Clinical Trials Market Size YoY Growth (2015-2026)
  • 1.6.1 North America Virtual Clinical Trials Market Size YoY Growth (2015-2026)
  • 1.6.2 Europe Virtual Clinical Trials Market Size YoY Growth (2015-2026)
  • 1.6.3 Asia-Pacific Virtual Clinical Trials Market Size YoY Growth (2015-2026)
  • 1.6.4 Latin America Virtual Clinical Trials Market Size YoY Growth (2015-2026)
  • 1.6.5 Middle East & Africa Virtual Clinical Trials Market Size YoY Growth (2015-2026)

2 Virtual Clinical Trials Market Overview by Type

• 2.1 Global Virtual Clinical Trials Market Size by Type: 2015 VS 2020 VS 2026
• 2.2 Global Virtual Clinical Trials Historic Market Size by Type (2015-2020)
• 2.3 Global Virtual Clinical Trials Forecasted Market Size by Type (2021-2026)
• 2.4 Interventional Trials
• 2.5 Observational Trials
• 2.6 Expanded Access Trials

3 Virtual Clinical Trials Market Overview by Application

• 3.1 Global Virtual Clinical Trials Market Size by Application: 2015 VS 2020 VS 2026
• 3.2 Global Virtual Clinical Trials Historic Market Size by Application (2015-2020)
• 3.3 Global Virtual Clinical Trials Forecasted Market Size by Application (2021-2026)
• 3.4 Oncology
• 3.5 Cardiovascular Disease
• 3.6 Others

4 Global Virtual Clinical Trials Competition Analysis by Players

• 4.1 Global Virtual Clinical Trials Market Size (Million US$) by Players (2015-2020)
• 4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Virtual Clinical Trials as of 2019)
• 4.3 Date of Key Manufacturers Enter into Virtual Clinical Trials Market
• 4.4 Global Top Players Virtual Clinical Trials Headquarters and Area Served
• 4.5 Key Players Virtual Clinical Trials Product Solution and Service
• 4.6 Competitive Status
  • 4.6.1 Virtual Clinical Trials Market Concentration Rate
  • 4.6.2 Mergers & Acquisitions, Expansion Plans

5 Company (Top Players) Profiles and Key Data

• 5.1 ICON Plc
  • 5.1.1 ICON Plc Profile
  • 5.1.2 ICON Plc Main Business
  • 5.1.3 ICON Plc Products, Services and Solutions
  • 5.1.4 ICON Plc Revenue (US$ Million) & (2015-2020)
  • 5.1.5 ICON Plc Recent Developments
• 5.2 LEO Innovation Lab
  • 5.2.1 LEO Innovation Lab Profile
  • 5.2.2 LEO Innovation Lab Main Business and Company’s Total Revenue
  • 5.2.3 LEO Innovation Lab Products, Services and Solutions
  • 5.2.4 LEO Innovation Lab Revenue (US$ Million) (2015-2020)
  • 5.2.5 LEO Innovation Lab Recent Development and Reaction to Covid-19
• 5.3 Science 37
  • 5.5.1 Science 37 Profile
  • 5.3.2 Science 37 Main Business
  • 5.3.3 Science 37 Products, Services and Solutions
  • 5.3.4 Science 37 Revenue (US$ Million) & (2015-2020)
  • 5.3.5 PRA Health Sciences Recent Developments
• 5.4 PRA Health Sciences
  • 5.4.1 PRA Health Sciences Profile
  • 5.4.2 PRA Health Sciences Main Business
  • 5.4.3 PRA Health Sciences Products, Services and Solutions
  • 5.4.4 PRA Health Sciences Revenue (US$ Million) & (2015-2020)
  • 5.4.5 PRA Health Sciences Recent Developments
• 5.5 Clinical Ink
  • 5.5.1 Clinical Ink Profile
  • 5.5.2 Clinical Ink Main Business
  • 5.5.3 Clinical Ink Products, Services and Solutions
  • 5.5.4 Clinical Ink Revenue (US$ Million) & (2015-2020)
  • 5.5.5 Clinical Ink Recent Developments
• 5.6 Parexel
  • 5.6.1 Parexel Profile
  • 5.6.2 Parexel Main Business
  • 5.6.3 Parexel Products, Services and Solutions
  • 5.6.4 Parexel Revenue (US$ Million) & (2015-2020)
  • 5.6.5 Parexel Recent Developments
• 5.7 Medable
  • 5.7.1 Medable Profile
  • 5.7.2 Medable Main Business and Company’s Total Revenue
  • 5.7.3 Medable Products, Services and Solutions
  • 5.7.4 Medable Revenue (US$ Million) (2015-2020)
  • 5.7.5 Medable Recent Development and Reaction to Covid-19
• 5.8 Oracle
  • 5.8.1 Oracle Profile
  • 5.8.2 Oracle Main Business
  • 5.8.3 Oracle Products, Services and Solutions
  • 5.8.4 Oracle Revenue (US$ Million) & (2015-2020)
  • 5.8.5 Oracle Recent Developments
• 5.9 CRF Health
  • 5.9.1 CRF Health Profile
  • 5.9.2 CRF Health Main Business
  • 5.9.3 CRF Health Products, Services and Solutions
  • 5.9.4 CRF Health Revenue (US$ Million) & (2015-2020)
  • 5.9.5 CRF Health Recent Developments
• 5.10 Medidata
  • 5.10.1 Medidata Profile
  • 5.10.2 Medidata Main Business
  • 5.10.3 Medidata Products, Services and Solutions
  • 5.10.4 Medidata Revenue (US$ Million) & (2015-2020)
  • 5.10.5 Medidata Recent Developments
• 5.11 Covance
  • 5.11.1 Covance Profile
  • 5.11.2 Covance Main Business
  • 5.11.3 Covance Products, Services and Solutions
  • 5.11.4 Covance Revenue (US$ Million) & (2015-2020)
  • 5.11.5 Covance Recent Developments
• 5.12 IQVIA
  • 5.12.1 IQVIA Profile
  • 5.12.2 IQVIA Main Business
  • 5.12.3 IQVIA Products, Services and Solutions
  • 5.12.4 IQVIA Revenue (US$ Million) & (2015-2020)
  • 5.12.5 IQVIA Recent Developments

6 North America

• 6.1 North America Virtual Clinical Trials Market Size by Country
• 6.2 United States
• 6.3 Canada

7 Europe

• 7.1 Europe Virtual Clinical Trials Market Size by Country
• 7.2 Germany
• 7.3 France
• 7.4 U.K.
• 7.5 Italy
• 7.6 Russia
• 7.7 Nordic
• 7.8 Rest of Europe

8 Asia-Pacific

• 8.1 Asia-Pacific Virtual Clinical Trials Market Size by Region
• 8.2 China
• 8.3 Japan
• 8.4 South Korea
• 8.5 Southeast Asia
• 8.6 India
• 8.7 Australia
• 8.8 Rest of Asia-Pacific

9 Latin America

• 9.1 Latin America Virtual Clinical Trials Market Size by Country
• 9.2 Mexico
• 9.3 Brazil
• 9.4 Rest of Latin America

10 Middle East & Africa

• 10.1 Middle East & Africa Virtual Clinical Trials Market Size by Country
• 10.2 Turkey
• 10.3 Saudi Arabia
• 10.4 UAE
• 10.5 Rest of Middle East & Africa

11 Virtual Clinical Trials Market Dynamics

• 11.1 Industry Trends
• 11.2 Market Drivers
• 11.3 Market Challenges
• 11.4 Market Restraints

12 Research Finding /Conclusion

13 Methodology and Data Source

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Disclaimer

Virtual Clinical Trials (VCTs), also called remote or decentralized trials, are a relatively new and yet underutilized method of conducting clinical research taking full advantage of technologies such as apps, electronic monitoring devices, and online social engagement platforms.
Virtual clinical trials (VCT) eliminate challenges posed by traditional clinical trials such as time-consuming procedures and delay in patient recruitment that has driven the demand for the virtual clinical trial market. Moreover, technological advancements in healthcare infrastructure and alliances between biotechnology, pharmaceutical & clinical research organization are anticipated to boost the virtual clinical trials market growth in the near future.

Market Analysis and Insights: Global Virtual Clinical Trials Market
The research report studies the Virtual Clinical Trials market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.
The global Virtual Clinical Trials market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Virtual Clinical Trials Scope and Segment
The global Virtual Clinical Trials market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Virtual Clinical Trials market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2015-2026.
by Type, the market is primarily split into
Interventional Trials
Observational Trials
Expanded Access Trials
by Application, this report covers the following segments
Oncology
Cardiovascular Disease
Others
Global Virtual Clinical Trials market: regional analysis, the major regions covered in the report are:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
The report lists the major players in the regions and their respective market share on the basis of global revenue. It also explains their strategic moves in the past few years, investments in product innovation, and changes in leadership to stay ahead in the competition. This will give the reader an edge over others as a well-informed decision can be made looking at the holistic picture of the market.
The Virtual Clinical Trials key players in this market include:
ICON Plc
LEO Innovation Lab
Science 37
PRA Health Sciences
Clinical Ink
Parexel
Medable
Oracle
CRF Health
Medidata
Covance
IQVIA